MedPath

SIMPONI

SIMPONI

Approved
DIN Number

02413175

Drug Class

Human

Market Date

Oct 3, 2013

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02413175
AIG Number0152549001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AB06 GOLIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

GOLIMUMABActive
Strength: 100 MG / 1.0 ML
Monograph: GOLIMUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.